WO2016016446A1 - Process for preparing 2-fluoropropionaldehyde - Google Patents
Process for preparing 2-fluoropropionaldehyde Download PDFInfo
- Publication number
- WO2016016446A1 WO2016016446A1 PCT/EP2015/067716 EP2015067716W WO2016016446A1 WO 2016016446 A1 WO2016016446 A1 WO 2016016446A1 EP 2015067716 W EP2015067716 W EP 2015067716W WO 2016016446 A1 WO2016016446 A1 WO 2016016446A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fluoropropionic
- mixture
- acid halide
- bases
- solvents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
- C07D323/04—Six-membered rings
- C07D323/06—Trioxane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
- C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/58—Preparation of carboxylic acid halides
- C07C51/60—Preparation of carboxylic acid halides by conversion of carboxylic acids or their anhydrides or esters, lactones, salts into halides with the same carboxylic acid part
Definitions
- the present invention relates to a novel synthesis for preparing 2-fluoropropionaldehyde.
- the present invention further relates to the use of 2-fluoropropionaldehyde as a substrate for an aldol condensation reaction.
- the present invention further relates to the use of 2- fluoropropionaldehyde as a reagent in an aldol condensation reaction, preferably in an enzymatic aldol condensation reaction.
- the present invention further relates to the use of 2- fluoropropionaldehyde for preparing nucleoside phosphoramidate derivatives such as sofos- buvir and intermediates for the synthesis of nucleoside phosphoramidate derivatives such as sofosbuvir.
- the problem underlying the present invention is the provision of a novel process for the preparation of 2-fluoropropionaldehyde which is carried out in mild and simple conditions, is economic and provides 2-fluoropropionaldehyde in good yields and leads to a product easy to be purified, which can be directly used in subsequent reactions such as in aldol reactions for example for the preparation of 2'-deoxy-2-fluoro-2'C-methyluridine and, hence, of sofosbuvir.
- the present invention relates to a process comprising
- the 2-fluoropropionic acid halide provided in (i) is 2- fluoropropionic acid chloride, 2-fluoropropionic acid bromide or 2-fluoropropionic acid iodide, preferably 2-fluoropropionic acid chloride or 2-fluoropropionic acid bromide.
- the 2-fluoropropionic acid halide is provided in (i) as (S)-2-fluoropropionic acid halide, as (R)-2-fluoropropionic acid halide, or as a mixture of (S)-2-fluoropropionic acid halide and (R)-2-fluoropropionic acid halide, for example comprising from 0.1 to 99.9 mol-% of the 2-fluoropropionic acid halide as (S)-2-fluoropropionic acid halide and from 99.9 to 0.01 mol-% of the 2-fluoropropionic acid halide as (R)-2-fluoropropionic acid halide, such as a racemic mixture of (S)-2-fluoropropionic acid halide and (R)-2-fluoropropionic acid halide.
- the 2-fluoropropionic acid halide is provided in (i), with the proviso that it can be subjected to the hydrogenation reaction according to (ii).
- the 2-fluoropropionic acid halide is provided comprised in a mixture which subjected to (ii).
- this mixture comprises one or more suitable solvents, preferably one or more organic solvents.
- suitable solvents preferably one or more organic solvents.
- one or more aprotic organic solvents are preferred.
- Apolar aprotic solvents are conceivable, including toluene, xylene, cyclohexane, hexane, heptane, diethyl ether, me- thyl-tert-butyl ether, diisopropyl ether.
- Preferred solvents are polar aprotic solvents, preferably including acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, ethyl acetate, methyl ethyl ketone, and butyl acetate, more preferably being selected from the group consisting of acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, methyl ethyl ketone, and butyl acetate.
- Tetrahydrofuran and ethyl acetate are especial- ly preferred solvents.
- the present invention relates to the process as defined above, wherein the 2- fluoropropionic acid halide is provided comprised in a mixture comprising a solvent selected from the group consisting of toluene, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, methyl ethyl ketone, ethyl acetate and butyl acetate, preferably in a mixture comprising tetrahydrofuran as solvent.
- a solvent selected from the group consisting of toluene, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, methyl ethyl ketone, ethyl acetate and butyl acetate, preferably in a mixture comprising tetrahydrofuran as solvent.
- the mixture provided in (i) which comprises the 2-fluoropropionic acid halide further comprises one or more bases preferably one or more organic bases and/or one or more inorganic bases.
- inorganic acids include carbonates, alkali metal and alkaline earth metal carbonates, such as Na 2 C0 3 , K 2 C0 3 , Ba 2 C0 3 , Ca 2 C0 3 , Cs 2 C0 3 and Li 2 C0 3 .
- the mixture provided in (i) which comprises the 2-fluoropropionic acid halide further comprises one or more organic bases.
- Preferred organic bases include amines, amidines, heterocyclic compounds comprising a basic nitrogen atom in the cycle, and mixtures of two or more thereof.
- the one or more organic bases are organic tertiary nitrogen bases, wherein, more preferably, the organic tertiary nitrogen bases do not comprise primary amino groups or secondary amino groups, preferable neither primary amino groups nor secondary amino groups.
- Preferred organic tertiary nitrogen bases include ⁇ , ⁇ '-diisopropylethylamine, triethylamine, l,8-diazabicycloundec-7-ene, pyridine, quinoline, isoquinoline, acridine, pyrazine, and imidazole, preferably one or more of ⁇ , ⁇ '-diisopropylethylamine, triethylamine, 1,8-diazabi- cycloundec-7-ene, and pyridine.
- organic tertiary nitrogen bases include N,N'-di- isopropylethylamine and triethylamine.
- the one or more bases and the 2-fluoropropionic acid halide are present in the mixture provided in (i) in a molar ratio of the one or more bases relative to the 2-fluoropropionic acid halide in the range of from 0.1 : 1 to 3 : 1, preferably in the range of from 0.75 : 1 to 1.5 : 1, more preferably in the range of from 0.95 : 1 to 1.05 : 1.
- the molar ratios relate to the total molar amount of all bases.
- the present invention relates to the process as defined above, wherein the 2- fluoropropionic acid halide is provided comprised in a mixture comprising a solvent selected from the group consisting of toluene, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, methyl ethyl ketone, ethyl acetate and butyl acetate, preferably in a mixture comprising tetrahydrofuran or ethyl acetate as solvent, and an organic base selected from the group consisting of ⁇ , ⁇ '-diisopropylethylamine and triethylamine, wherein the molar ratio of the one or more bases relative to the 2-fluoro-propionic-acid halide is preferably the range of from 0.95 : 1 to 1.05 : 1.
- the base neutralizes the hydrogen halide which is formed during the hydrogenation reaction of the 2-fluoropropionic acid halide. Therefore, in case a base is present, a hydrogen halide -base salt may be formed during the reaction.
- the one or more bases may serve for neutralizing the acid formed during the reaction by forming a salt.
- the mixture obtained according to the below step (ii) may additionally contain the hydrogen halide salt of the one or more bases.
- the base may be selected considering whether the salt of the base and acid formed during the reaction is insoluble under the separation conditions and optionally under the process conditions and can be easily separated, for example by filtration.
- the mixture provided in (i) which comprises the 2-fluoropropionic acid halide further comprises a solid porous adsorbent.
- the solid porous adsorbent may adsorb the water possibly formed during the hydrogenation process, or absorb any residual water possibly present in the one or more solvent and/or the reagents that might hydrolyze the acid halide, thus possibly resulting in a low- er reaction yield, and possibly prevent the formation of by-products, for example due to the condensation of the halide with the corresponding acid.
- Preferred solid porous adsorbents include molecular sieves.
- the solid porous adsorbent preferably the molecular sieve, is a microporous compound having a pore size of less than 2 nm, determined according to DIN 66135-2. More preferably, the pore size in the range of from 0.35 to 0.45 nm, determined according to DIN 66135-2.
- the present invention relates to the process as defined above, wherein the 2- fluoropropionic acid halide is provided comprised in a mixture comprising a solvent selected from the group consisting of tetrahydrofuran, ethyl acetate and toluene, preferably in a mixture comprising tetrahydrofuran as solvent, and a microporous molecular sieve, preferably having a pore size in the range of from 0.35 to 0.45 nm, determined according to DIN 66135- 2.
- a solvent selected from the group consisting of tetrahydrofuran, ethyl acetate and toluene, preferably in a mixture comprising tetrahydrofuran as solvent
- a microporous molecular sieve preferably having a pore size in the range of from 0.35 to 0.45 nm, determined according to DIN 66135- 2.
- the present invention relates to the process as defined above, wherein the 2- fluoropropionic acid halide is provided comprised in a mixture comprising a solvent selected from the group consisting of toluene, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, methyl ethyl ketone, ethyl acetate and butyl acetate, preferably in a mixture comprising tetrahydrofuran or ethyl acetate as solvent, an organic base selected from the group consisting of ⁇ , ⁇ '-diisopropylethylamine and triethylamine, wherein the molar ratio of the one or more bases relative to the 2-fluoro-propionic-acid halide is preferably the range of from 0.95 : 1 to 1.05 : 1, and a microporous molecular sieve, preferably having a pore size in the
- the 2-fluoropropionic acid halide is hydrogenated by contacting it with a heterogeneous hydrogenation catalyst in an atmosphere comprising hydrogen, obtaining a mixture comprising 2-fluoropropionic aldehyde.
- a heterogeneous hydrogenation catalyst is a solid catalyst which, more preferably, comprises one or more hydrogenation-active metals.
- these hydrogenation-active metals which preferably include one or more of palladium, platinum, rhodium, ruthenium, nickel and iridium, more preferably palladium and platinum.
- the heterogeneous hydrogenation catalyst according to (ii) comprises palladium. While it is conceivable that the hydrogenation-active metal is employed as such, it is preferred that the one or more the hydrogenation-active metals are employed supported in one or more suitably supports. No specific limitations exist with regard to these supports provided that they can be employed in the hydrogenation reaction according to (ii) and are substantially inert under the reaction conditions.
- Preferred supports are oxidic supports and preferably in- elude one or more of silica, titania, alumina, preferably gamma-alumina, mixed oxides of two or more thereof, sulfates, preferably alkaline earth metal sulfates, carbonates, preferably alkaline earth metal carbonates. More preferably, the oxidic support comprises calcium carbonate or barium sulfate. More preferably, the oxidic support comprises, more preferably is, barium sulfate.
- the present invention relates to the process as defined above, wherein the 2- fluoropropionic acid halide is provided comprised in a mixture comprising a solvent selected from the group consisting of toluene, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, methyl ethyl ketone, ethyl acetate and butyl acetate, preferably in a mixture comprising tetrahydrofuran or ethyl acetate as solvent, and a microporous molecular sieve, preferably having a pore size in the range of from 0.35 to 0.45 nm, determined according to DIN 66135-2, and wherein the mixture is subjected in (ii) to hydrogenation reaction conditions in the presence of a heterogeneous hydrogenation catalyst, preferably palladium supported in barium sulfate or calcium carbonate.
- a heterogeneous hydrogenation catalyst
- the present invention relates to the process as defined above, wherein the 2- fluoropropionic acid halide is provided comprised in a mixture comprising a solvent selected from the group consisting of toluene, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, methyl ethyl ketone, ethyl acetate and butyl acetate, preferably in a mixture comprising tetrahydrofuran or ethyl acetate as solvent, an organic base selected from the group consisting of ⁇ , ⁇ '-diisopropylethylamine and triethylamine, wherein the molar ratio of the one or more bases relative to the 2-fluoro-propionic-acid halide is preferably the range of from 0.95 : 1 to 1.05 : 1, and a microporous molecular sieve, preferably having a pore size in the
- the acid halide is selectively dehalogenated to give the corresponding aldehyde. More surprisingly, substantially no reductive dehalogenation of the fluoro residue in alpha position to the carboxyl group has been observed.
- J. Am. Chem. Soc. JACS 1987, 109, 7714-7720, the present invention provides the advantage of the use of a catalyst that does not contain toxic moieties such as carbon monoxide and that is easily separable from the solution in which the hydrogenation reaction is carried out.
- the present invention provides an easily separable catalyst as well. It is conceivable that the heterogeneous catalyst may optionally be suitably poisoned by any method known in the art, for example to avoid a further reduction of the aldehyde product to the corresponding alcohol.
- the amount of the heterogeneous catalyst it is preferred that it is employed at a molar ratio of the heterogeneous catalyst relative to the 2-fluoropropionic acid halide in the range of from 0.01 : 1 to 1 : 1, more preferably in the range of from 0.05 : 1 to 0.6 : 1, more preferably in the range of from 0.06 : 1 to 0.5 : 1.
- At least 90 volume- more preferably at least 95 volume-%, more preferably at least 99 volume-% of the atmosphere comprising hydrogen consist of hydrogen.
- the hydrogenating according to (ii) is carried out at a hydrogen pressure in the range of from 0.5 to 2.0 bar, preferably in the range of from 0.7 to 1.7 bar, more preferably in the range of from 1.0 to 1.2 bar.
- the present invention advantageously provides a process that can be carried out much milder pressure conditions. While the hydroformylation disclosed in JACS is carried out at a pressure of 68 to 110 atm, corresponding to 68.9 to 111.4 bar, the present process can be carried out at a far lower pressure. This allows for having a simpler and more economic reaction avoiding the problem generically associated with the carrying out of a reaction at a high pressure.
- the hydrogenating according to (ii) is carried at a temperature of the atmosphere comprising hydrogen in the range of from 10 to 40 °C, more preferably in the range of from 15 to 35 °C, more preferable in the range of from 20 to 30 °C.
- the present invention provides a hydrogenation process that can be carried out at much milder temperature condition. While the hydroformylation disclosed in JACS is carried out at a temperature of 80 to 100 °C, the present process can be carried out at a far lower temperature, resulting in a simpler and more economic process.
- the present invention provides a simpler and more economic process as temperature of -80 °C can be avoided.
- the hydrogenation reaction according to (ii) is generally carried out by stirring the mixture as disclosed above under an atmosphere comprising hydrogen as disclosed above for a time sufficient to give the 2-fluoropropionic aldehyde.
- the hydrogenating according to (ii) is carried for a period of time in the range of from 1 to 24 h, more preferably in the range of from 2 to 8 h.
- the hydrogenation reaction according to (ii) can be carried out in batch mode, semi-continuous mode, or continuous mode. If it is carried in continuous mode, it can be carried out in either a fluidized bed or a fi ed bed.
- the heterogeneous hydrogenation catalyst is kept suspended in a portion of the mixture which is maintained in the reactor whereas in a fixed-bed reactor, the heterogeneous hydrogenation catalyst is maintained during the reaction in the form of a fixed catalyst bed, and the mixture and atmosphere comprising the hydrogen are continuously passed through the respective bed.
- the present invention relates to the process as defined above, wherein the 2- fluoropropionic acid halide is provided comprised in a mixture comprising a solvent selected from the group consisting of toluene, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, methyl ethyl ketone, ethyl acetate and butyl acetate, preferably in a mixture comprising tetrahydrofuran or ethyl acetate as solvent, and a microporous molecular sieve, preferably having a pore size in the range of from 0.35 to 0.45 nm, determined according to DIN 66135-2, and wherein the mixture is subjected in (ii) to hydrogenation reaction conditions in the presence of a heterogenous hydrogenation catalyst, preferably palladium supported in barium sulfate or calcium carbonate, wherein the hydrogenation reaction conditions comprise a temperature
- the present invention relates to the process as defined above, wherein the 2- fluoropropionic acid halide is provided comprised in a mixture comprising a solvent selected from the group consisting of toluene, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, methyl ethyl ketone, ethyl acetate and butyl acetate, preferably in a mixture comprising tetrahydrofuran or ethyl acetate as solvent, an organic base selected from the group consisting of ⁇ , ⁇ '-diisopropylethylamine and triethylamine, wherein the molar ratio of the one or more bases relative to the 2-fluoro-propionic-acid halide is preferably the range of from 0.95 : 1 to 1.05 : 1, and a microporous molecular sieve, preferably having a pore size in the
- the 2-fluoropropionic acid halide is provided in (i) as (S)-2-fluoropropionic acid halide
- the 2-fluoropropionic aldehyde obtained in (ii) is (S)-2-fluoropropionic aldehyde.
- the 2-fluoropropionic acid halide is provided in (i) as (R)-2- fluoropropionic acid halide
- the 2-fluoropropionic aldehyde obtained in (ii) is (R)-2- fluoropropionic aldehyde.
- the 2-fluoropropionic acid halide is provided in (i) as as a mixture of (S)-2-fluoropropionic acid halide and (R)-2-fluoropropionic acid halide, for example comprising from 0.1 to 99.9 mol-% of the 2-fluoropropionic acid halide as (S)-2- fluoropropionic acid halide and from 99.9 to 0.01 mol-% of the 2-fluoropropionic acid halide as (R)-2-fluoropropionic acid halide, such as a racemic mixture of (S)-2-fluoropropionic acid halide and (R)-2-fluoropropionic acid halide, the 2-fluoropropionic aldehyde obtained in (ii) is a mixture of (S)- 2-fluoropropionic aldehyde and (R)- 2-fluoropropionic aldehyde, for example comprising from 0.1 to 99
- the present inven- tion also relates to the process as defined above, further comprising
- the separating according to (iii) comprises subjecting the mixture obtained in (ii) to solid phase separation wherein the solids comprised in the mixture are separated from the liquid phase.
- the mixture obtained from (ii) additionally comprises the solid porous ad- sorbent and optionally the possibly solid hydrogen halide salt of the one or more bases.
- the heterogeneous hydrogenation catalyst, the solid porous adsorbent and optionally the solid hydrogen halide salt of the one or more bases is separated from the liquid phase of the mixture obtained from (ii) comprising the 2-fluoropropionic aldehyde.
- the solid phase separation according to (iii) comprises centrifugation or filtration, preferably filtration.
- the present invention relates to the process as defined above, wherein the 2- fluoropropionic acid halide is provided comprised in a mixture comprising a solvent selected from the group consisting of toluene, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, methyl ethyl ketone, ethyl acetate and butyl acetate, preferably in a mixture comprising tetrahydrofuran or ethyl acetate as solvent, and a microporous molecular sieve, preferably having a pore size in the range of from 0.35 to 0.45 nm, determined accord- ing to DIN 66135-2, wherein the mixture is subjected in (ii) to hydrogenation reaction conditions in the presence of a heterogeneous hydrogenation catalyst, preferably palladium supported in barium sulfate or calcium carbonate, wherein the hydrogenation reaction conditions comprise
- the present invention relates to the process as defined above, wherein the 2- fluoropropionic acid halide is provided comprised in a mixture comprising a solvent selected from the group consisting of toluene, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, methyl ethyl ketone, ethyl acetate and butyl acetate, preferably in a mixture comprising tetrahydrofuran or ethyl acetate as solvent, an organic base selected from the group consisting of ⁇ , ⁇ '-diisopropylethylamine and triethylamine, wherein the molar ratio of the one or more bases relative to the 2-fluoro-propionic-acid halide is preferably the range of from 0.95 : 1 to 1.05 : 1, and a microporous molecular sieve, preferably having a pore size in the
- the liquid phase obtained comprising the one or more solvents and the 2-fluoropropionic aldehyde
- the 2-fluoropropionic aldehyde can be separated from the solvent via distillation.
- the liquid phase obtained, comprising the one or more solvents and the 2-fluoropropionic aldehyde is subjected to extraction wherein the 2-fluoropropionic aldehyde is suitably extracted.
- the present invention also relates to the process as defined above, wherein according to (i), the 2-fluoropropionic acid halide is provided comprised in a mixture comprising one or more organic solvents and wherein from (iii), a mixture is obtained comprising the 2- fluoropropionic aldehyde and the one or more solvents, further comprising
- the one or more solvents according to (iv) include water and one or more organic solvents, preferably including pentane, hexane, heptane, cyclohexane, ethyl acetate, methyl isobutyl ketone, methyl tert-butyl ether, diisopropyl ether, and methyl tetrahydrofuran.
- the one or more solvents according to (iv) are water or a mixture of water and one or more organic solvents. More preferably, the solvent used in (iv) is water.
- the present invention relates to the process as defined above, wherein the 2- fluoropropionic acid halide is provided comprised in a mixture comprising a solvent selected from the group consisting of toluene, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, methyl ethyl ketone, ethyl acetate and butyl acetate, preferably in a mixture comprising tetrahydrofuran or ethyl acetate as solvent, and a microporous molecular sieve, preferably having a pore size in the range of from 0.35 to 0.45 nm, determined according to DIN 66135-2., wherein the mixture is subjected in (ii) to hydrogenation reaction conditions in the presence of a heterogeneous hydrogenation catalyst, preferably palladium supported in barium sulfate or calcium carbonate, wherein the hydrogenation reaction conditions comprise a
- the present invention relates to the process as defined above, wherein the 2- fluoropropionic acid halide is provided comprised in a mixture comprising a solvent selected from the group consisting of toluene, acetone, acetonitrile, dioxane, tetrahydrofuran (THF), methyl tetrahydrofuran, methyl ethyl ketone, ethyl acetate and butyl acetate, preferably in a mixture comprising tetrahydrofuran or ethyl acetate as solvent, an organic base selected from the group consisting of ⁇ , ⁇ '-diisopropylethylamine and triethylamine, wherein the molar ratio of the one or more bases relative to the 2-fluoro-propionic-acid halide is preferably the range of from 0.95 : 1 to 1.05 : 1, and a microporous molecular sieve, preferably having a pore size in the
- the 2-fluoropropionaldehyde can be present as trimeric compound. Therefore, the present invention also relates to the compound of formula (II)
- ( ⁇ ), which is at least partially dissolved in one or more solvents wherein the one or more solvents are preferably selected from the group consisting of water, one or more organic solvent, and a mixture of two or more thereof, wherein the one or more solvents preferably comprise, more preferably consist of, water.
- the 2-fluoropropionic acid halide according to (i) is prepared.
- it is prepared by a process comprising a) mesylating ethyl lactate, obtaining ethyl-2-((methylsulfonyl)oxy) propanoate;
- step i) fluorinating the ethyl-2-((methylsulfonyl)oxy)propanoate) of step i), obtaining 2- fluoropropanoate;
- the present invention also relates to a process for the preparation of a 2- fluoropropionic acid halide as such, comprising
- step i) fluorinating the ethyl-2-((methylsulfonyl)oxy)propanoate) of step i), obtaining 2- fluoropropanoate;
- Step a) As a general procedure, the mesylation of a) is carried out by adding ethyl lactate to a solution comprising an organic base or a combination of one or more organic bases.
- the one or more organic bases include ⁇ , ⁇ '-diisopropylethylamine, triethyla- mine, 4-dimethylaminopyridine, l,8-diazabicycloundec-7-ene, pyridine, quinoline, isoquino- line, acridine, pyrazine, and imidazole, preferably one or more of N,N'-diisopropylethylamine, triethylamine, and l,8-diazabicycloundec-7-ene.
- the one or more bases comprise triethylamine.
- the reaction can be carried out in a solution comprising one or more solvents.
- the one or more solvents include THF, MeTHF, dichloromethane, cyclo- hexane, hexane, heptane, toluene, xylene, acetonitrile, acetone, diethyl ether, methyl isobutyl ketone, methyl-tert-butyl ether, and diisopropyl ether.
- the one or more solvents comprise THF.
- the reaction according to a) is carried out at a temperature in the range of 40 to 80 °C, more preferably in the range of from 50 to 60 °C.
- Methanesulfonyl chloride is then preferably added, preferably drop-wise.
- the mixture is preferably allowed to warm up, prefer- ably to room temperature. It is preferred that then, the mixture is stirred for example for 6 h at a temperature elevated with respect to room temperature, preferably in the range of from 50 to 60 °C.
- the mixture is then preferably filtered and optionally washed.
- the solvent is then preferably removed, preferably under vacuum, to yield crude 2-((methylsulfonyl)oxy)- propanoate.
- the crude can be used without further purification.
- the 2-fluoropropanoic ester preferably 2-fluoropropanoic ethyl ester, can be prepared from 2-((methylsulfonyl)oxy)propanoate according to all suitable processes, such as disclosed in Tetrahedron Lett. 1993, 34(2), pages 293-296.
- the reaction is carried out in one or more solvents.
- the one or more solvents include formamide, acetamide, dimethylformamide, and dimethylacetamide. More preferably the one or more solvents comprise formamide.
- the reaction according to b) is carried out at a temperature in the range of from 40 to 90 °C, more preferably in the range of from 50 to 80 °C.
- the 2-fluoropropanoic ester is preferably prepared by reac- tion of the ethyl-2-((methylsulfonyl)oxy)propanoate) of step a), preferably in the presence of potassium fluoride and formamide at the conditions and time until the ester is formed.
- the 2-fluoropropanoic acid can be prepared from 2- fluoropropanoic ester, preferably the 2-fluoropropanoic ethyl ester, according to all suitable processes known in the art.
- the 2-fluoropropanoic acid is preferably prepared by hydrolyzing the ester of step b) in acidic condition such as in sulphuric acid conditions.
- step c) is preferably carried out at a pH in the range of from 1 to 5, preferably in the range of from 2 to 4.
- the 2-fluoropropionic acid halide can prepared from the 2-fluoropropanoic acid, according to all suitable processes known in the art.
- the process of step d) is preferably carried in one or more solvents.
- the one or more solvents preferably include dimethylformamide, dichloromethane, THF, MeTHF, diethyl ether, MTBE, and dioxane. More preferably, the one or more solvents comprise DMF.
- the reaction according to d) is carried out at a temperature in the range of from 40 to 60 °C, preferably in the range of from 45 to 55 °C.
- the 2-fluoropropionic acid halide is more preferably prepared by reaction of the acid of step c) in the presence of SOCl 2 in DMF at the conditions and time necessary for the acid halide to be formed.
- the 2-fluoropropionic aldehyde can be used directly in a further reaction.
- the 2-fluoropropionic aldehyde is reacted with a carbonyl compound in an aldol condensation reaction, preferably an enzymatic aldol condensation reaction.
- the aldol condensation reaction is carried out in the presence of a carbonyl com- pound, either an aldehyde or a ketone.
- the carbonyl compound is preferably a glyceraldehyde derivative, preferably a (D)-glyceraldehyde derivative.
- Glyceraldehyde is generally the starting molecule for the synthesis of further carbohydrates. Glyceraldehyde or derivatives thereof can be used according to the present invention to pre- pare a compound of formula (I) or diastereomers or stereoisomers thereof (I).
- the term "glyceraldehyde derivative" in the context of the present invention relates to a "protected glyceraldehyde” or an "activated glyceraldehyde".
- a protected glyceraldehyde is for example a glyceraldehyde wherein the OH groups in positions 2 and 3 are suitably protected to avoid side reactions during the aldol reaction.
- Any protecting group of OH groups or of diols suitable to be used in aldol reaction conditions can be used according to the present invention.
- a suitable protecting group of the diol moiety of glyceraldehyde is an acetal.
- An "activated glyceraldehyde" is for example a glyceraldehyde bearing a functional group that provides the glyceraldehyde in the suitable reactive form for the subsequent reac- tion.
- glyceraldehyde- 3 -phosphate is an activated form of glyceraldehyde in enzymatic reactions, such as an enzymatic aldol condensation reaction.
- An aldol condensation of (D)-glyceraldehyde-3-phosphate and 2-fluoropropionaldehyde carried out with deoxyri- bose-phosphate aldolase (DERA) leads, for example, to the compound of above formula (I).
- the enzymatic aldol condensation reaction of the present invention is preferably carried out with a ribose phosphatase- aldolase enzyme, more preferably a deoxyribose-phosphate aldolase (DERA) enzyme.
- the present invention also relates to a process comprising:
- step II providing a solution, preferably an aqueous solution, comprising the 2- fluoropropionaldehyde of step I);
- an aldol reaction preferably an enzymatic aldol reaction, even more preferably enzymatic aldol reaction carried out by a DERA enzyme, with a carbonyl compound, wherein the carbonyl compound is preferably a glyceraldehyde derivative, more preferably a protected or activated glyceraldehyde, obtaining the aldol condensation product of 2-fluoropropionaldehyde and the carbonyl compound.
- I) comprises preparing the 2-fluoropropionaldehyde with a heterogeneous catalyst reductive hydrogenation according to the present invention as disclosed above.
- I) comprises preparing the 2-fluoropropionaldehyde with a heterogeneous catalyst reductive hydrogenation of 2-fluoropropionic acid chloride according to the present invention as disclosed above wherein the heterogeneous catalyst is selected from the group consisting of Pd/BaS0 4 and Pd/CaC0 3 .
- III) comprises contacting the the 2-fluoropropionaldehyde in the solution of step II) with (D)-glyceraldehyde-3-phosphate and an enzyme, wherein the enzyme is preferably a DERA enzyme, obtaining the compound of formula (I) or diastereomers or stereoisomers thereof
- the compound of formula (I) can be obtained as a mixture of diastereoisomers
- Compounds (IA) and (IB) may optionally be separated before further use.
- III) is carried out in water.
- the 2-fluoropropionaldehyde is provided in II) in an aqueous solution.
- the compound obtained in III) may be used in the preparation of phosphoramidate derivatives such as nucleoside phosphoramidate that are useful in the synthesis of biologically or pharmaceutically active compounds such as sofosbuvir.
- the 2-fluoropropionic aldehyde or a solution thereof as disclosed above and prepared accord- ing to the process of the present invention or obtainable or obtained by the process of the present invention can be used as an intermediate for the synthesis of further compounds, for example for the preparation of biologically or pharmaceutically active compounds or intermediates of biologically or pharmaceutically active compounds.
- valuable biologically or pharmaceutically active compounds that are prepared using the 2-fluoropropane aldehyde or a solution thereof are 2'-fluoronucleoside and pentafuranose precursors thereof for the preparation of nucleoside phosphoramidates agents that are useful for treating viral diseases.
- sofosbuvir is a valuable compound that is prepared starting from the 2-fluoropropane aldehyde prepared according to the process of present invention, via intermediate of formula (I) and (I-A).
- Compound (I) or (I-A) is a known intermediated in the synthesis of sofosbuvir.
- the preparation of sofosbuvir starting from compound of formula (I) or (I-A) is disclosed for example in patent application WO 2008/121634.
- the 2-fluoropropionic aldehyde obtained or obtainable by the process of the invention is used as a reagent in aldol reaction, preferably, in an enzymatic aldol reaction.
- the aldol reaction is carried out with a glyceraldehyde derivative, preferably a (D)- glyceraldehyde derivative.
- a glyceraldehyde derivative preferably a (D)- glyceraldehyde derivative.
- the 2-fluoropropane aldehyde or a solution thereof obtained or obtainable by the process of the invention is used in an enzymatic aldol reaction to prepare the compound of formula (I) or diastereomers or ste (I).
- the compound of formula (I) is prepared by contacting a solution, preferably an aqueous solution, comprising 2-fluoropropionaldehyde and a glyceraldehyde derivative, preferably a D-glyceraldehyde-3-phosphate with an enzyme, preferably a deoxyribose-phosphate aldolase enzyme.
- a solution preferably an aqueous solution, comprising 2-fluoropropionaldehyde and a glyceraldehyde derivative, preferably a D-glyceraldehyde-3-phosphate
- an enzyme preferably a deoxyribose-phosphate aldolase enzyme.
- the compound of formula (I) can be obtained as a mixture of diastereoisomers. (IA) and (IB)
- Compounds (IA) and (IB) may optionally be separated before further use.
- the one or more organic solvents are one or more polar aprotic organic solvents.
- the one or more organic solvents are selected from the group consisting of toluene, acetone, acetonitrile, dioxane, tetrahydro- furan (THF), methyl tetrahydrofuran, methyl ethyl ketone, ethyl acetate and butyl acetate.
- the one or more bases are one or more of ⁇ , ⁇ '-diisopropylethylamine, triethylamine, l,8-diazabicycloundec-7-ene, pyridine, quinoline, isoquinoline, acridine, pyrazine, and imidazole, preferably one or more of ⁇ , ⁇ '-diisopropylethylamine, triethylamine, l,8-diazabicycloundec-7-ene, and pyridine.
- the one or more bases are one or more of ⁇ , ⁇ '- diisopropylethylamine and triethylamine.
- heterogeneous hydrogenation catalyst according to (ii) comprises a support, preferably an oxidic support.
- oxidic support is one or more of silica, tita- nia, alumina, preferably gamma-alumina, mixed oxides of two or more thereof, sulfates, preferably alkaline earth metal sulfates, carbonates, preferably alkaline earth metal carbonates.
- heterogeneous hydrogenation catalyst according to (ii) comprises, for example consists of, palladium supported on
- the one ore more solvents according to (iv) are water or a mixture of water and one or more organic solvents.
- the one or more organic solvents include pen- tane, hexane, heptane, cyclohexane, ethyl acetate, methyl isobutyl ketone, methyl tert- butyl ether, diisopropyl ether, and methyl tetrahydrofuran.
- step a) mesylating ethyl lactate, obtaining ethyl-2-((methylsulfonyl)oxy) propanoate; b) fluorinating the ethyl-2-((methylsulfonyl)oxy)propanoate) of step a), obtaining 2- fluoropropanoate;
- step d) converting the 2-fluoropropanoic acid of step c) to the corresponding 2-fluoro- propionc acid halide.
- aldol condensation reaction is an enzymatic aldol condensation reaction and wherein the enzymatic aldol reaction is carried out using a ribose phosphatase- aldolase enzyme.
- aldol condensation reaction is an enzymatic aldol condensation reaction and wherein the enzymatic aldol reaction is carried out in an aqueous solution.
- the 2-fluoropropionic acid halide is provided as a mixture of (S)-2-fluoropropionic acid halide and (R)-2- fluoropropionic acid halide, preferably comprising from 0.1 to 99.9 mol-% of the 2- fluoropropionic acid halide as (S)-2-fluoropropionic acid halide and from 99.9 to 0.01 mol-% of the 2-fluoropropionic acid halide as (R)-2-fluoropropionic acid halide.
- An aldol condensation process preferably an enzymatic aldol condensation process, comprising reaction 2-fluoropropionaldehyde with a carbonyl compound.
- Ar is phenyl, naphthyl, quinolinyl, isoquinolinyl, quinazolinyl or quinoxalinyl, each optionally substituted with at least one of Ci-C 6 alkyl, Ci-C 6 alkoxy, Ci-C 6 cycloalkyl, ar- yl, halogen, COOH, CHO, C(0)(Ci-C 6 alkyl), C(0)(aryl), COO(Ci-C 6 alkyl), COONH 2 , COONH(Ci-C 6 alkyl), and CN;
- R 2 and R3 are independently H or Ci-C 6 alkyl optionally substituted with at least one of OH, Ci-C 6 alkoxy, aryl, heteroaryl, Ci-C 6 alkyl, C 3 -C6 cycloalkyl, F, CI, Br, I, N0 2 , or carbonyl;
- R 6 is Ci-C 6 alkyl or C 3 -C 10 cycloalkyl optionally substituted with at least one of Ci-C 6 alkyl and aryl;
- Base is a purinyl residue or a pyrimidinyl residue linked to the furanose ring according to formula (III) through a carbon or nitrogen atom;
- R 7 and R 8 are independently H, OH, F, CI, Br, I, azide, nitrile, NH 2 , NHR 23 , NR 23 R 24 , (CO)-NH 2 , (CO)-NHR 23 , (CO)-NR 23 R 24 , Ci-C 6 alkyl optionally substituted with Ci-C 6 alkyl, or C3-C 10 cycloalkyl optionally substituted with Ci-C 6 alkyl, wherein R 23 and R 24 are independently Ci-C 6 alkyl;
- R 9 is H, OH, Ci-C 6 alkoxy, SiR a R b R c , OC(0)R 25 , or C C 6 alkyl optionally substituted with Ci-C 6 alkyl or aryl, wherein R 25 is Ci-C 6 alkyl or aryl, and wherein R a , Rb, R c are independently Ci-C 6 alkyl or aryl.
- the compound of embodiment 83 at least partially dissolved in one or more solvents, wherein the one or more solvents are preferably selected from the group consisting of water, one or more organic solvent, and a mixture of two or more thereof, wherein the one or more solvents preferably comprise, more preferably consist of, water.
- step a) mesylating ethyl lactate, obtaining ethyl-2-((methylsulfonyl)oxy) propanoate; b) fluorinating the ethyl-2-((methylsulfonyl)oxy)propanoate) of step a), obtaining 2- fluoropropanoate;
- step d) converting the 2-fluoropropanoic acid of step c) to the corresponding 2-fluoro- propionc acid halide.
- 2-Fluoropropionic acid chloride 500 mg, 4.5 mmol
- Reference Example 4 2-Fluoropropionic acid chloride (500 mg, 4.5 mmol) according to Reference Example 4 was dissolved in 8 mL THF and 1.32 g molecular sieve (powdered, 4 Angstrom pore size) and the heterogeneous hydrogenation catalyst Pd/BaSO 4 (560 mg, 5 weight- % Pd, 10 mmol, 6 mol-%) were added.
- the mixture was stirred at a temperature of 23 to 25 °C under a hydrogen atmosphere at a hydrogen pressure of about 1 atm for 3 hours, providing 2- fluoropropionaldehyde in 47 % yield.
- the yield was determined via HPLC by derivatizing the aldehyde sample to the 2,4- dinitrophenyl hydrazone. Characterization of the product:
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14179387 | 2014-07-31 | ||
EP14179387.7 | 2014-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016016446A1 true WO2016016446A1 (en) | 2016-02-04 |
Family
ID=51257396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2015/067716 WO2016016446A1 (en) | 2014-07-31 | 2015-07-31 | Process for preparing 2-fluoropropionaldehyde |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2016016446A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109794296A (en) * | 2018-12-29 | 2019-05-24 | 濮阳宏业高新科技发展有限公司 | A kind of mixed acid solid-carried catalyst and the application in catalysis n-butanal or the reaction of isobutylaldehyde cyclic trimerization |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS617228A (en) * | 1984-06-22 | 1986-01-13 | Sagami Chem Res Center | Preparation of 2-fluoropropanal |
-
2015
- 2015-07-31 WO PCT/EP2015/067716 patent/WO2016016446A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS617228A (en) * | 1984-06-22 | 1986-01-13 | Sagami Chem Res Center | Preparation of 2-fluoropropanal |
Non-Patent Citations (4)
Title |
---|
BERGMANN ET AL., TETRAHEDRON LETTERS, vol. 6, no. 17, 1965, pages 1151 - 1153, XP009179846 * |
C. BOTTEGHI ET AL.: "A new preparative route to .alpha.-fluoroacrylic acid", JOURNAL OF FLUORINE CHEMISTRY, vol. 107, no. 1, 2001, pages 113 - 116, XP002730374, ISSN: 0022-1139 * |
CAVALLERI B ET AL: "Composti Organici Fluorurati A Potenziale Attitiva Biolgica. Nota III. Derivati dell'acido [alpha-]fluorofenilacetico", FARMACO, EDIZIONE SCIENTIFICA, SOCIETA CHIMICA ITALIANA, PAVIA, IT, vol. 23, 1 January 1968 (1968-01-01), pages 1127 - 1140, XP009185811, ISSN: 0430-0920 * |
E. ELKIK: "Aldéhydes .alpha.-fluorés. I. Aldéhydes aliphatiques saturés", BULLETIN DE LA SOCIETE CHIMIQUE DE FRANCE, no. 9, 1964, pages 2254 - 2257, XP002730373, ISSN: 0037-8968 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109794296A (en) * | 2018-12-29 | 2019-05-24 | 濮阳宏业高新科技发展有限公司 | A kind of mixed acid solid-carried catalyst and the application in catalysis n-butanal or the reaction of isobutylaldehyde cyclic trimerization |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6573848B2 (en) | Method for synthesizing entecavir and intermediate compound thereof | |
WO1999001420A1 (en) | Process for the preparation of 2-aminomalonic acid derivatives and intermediates used in the process | |
JP2008505981A (en) | Method for preparing cinacalcet hydrochloride | |
US20110244531A1 (en) | Synthesis routes to 2(s),4(s),5(s),7(s)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides | |
US20170218006A1 (en) | Synthesis of Phosphoramidates | |
KR100877849B1 (en) | Process for the efficient preparation of 3-hydroxytetrahydrofuran | |
WO2016016446A1 (en) | Process for preparing 2-fluoropropionaldehyde | |
US6960680B2 (en) | Manufacture of water-soluble β-hydroxynitriles | |
KR100714197B1 (en) | Process for the preparation of voglibose | |
JP2008063335A (en) | Method for producing 1,2-diol from carbonyl compound | |
US20230140054A1 (en) | Methods, processes and intermediates for preparing chroman compounds | |
JP2008007457A (en) | POST-TREATMENT METHOD OF beta-HYDROXYCARBONYL COMPOUND | |
KR101259648B1 (en) | A manufacturing process of 2′,2′-difluoronucloside and intermediate | |
CN113121413B (en) | Preparation method of key intermediate of JAK3 enzyme inhibitor | |
JP5115762B2 (en) | Process for producing 4-formylpiperidine acetal derivative | |
KR100658906B1 (en) | Process for the preparation of voglibose | |
JP4829418B2 (en) | Optically active halohydrin derivative and method of using the same | |
JPS6121624B2 (en) | ||
WO2023100110A1 (en) | Process for preparing brivaracetam | |
JPH0217198A (en) | Production of 2'-deoxy-beta-cytidine derivative and salt thereof | |
KR101473646B1 (en) | PROCESS FOR PREPARING 3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indole-2-yl]-2-propenal | |
KR101388770B1 (en) | Manufacturing method of urocanic acid using novel intermediate compound | |
CN1262549C (en) | Process for the preparation of 5-formyl-2- benzo[c]usfuran ketone | |
KR100684081B1 (en) | Preparation of optically active 3,4-dihydrobenzoxazine derivative | |
CN103201252A (en) | Preparation method of cinacalcet and pharmaceutical salts thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15742322 Country of ref document: EP Kind code of ref document: A1 |
|
REEP | Request for entry into the european phase |
Ref document number: 2015742322 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15742322 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15742322 Country of ref document: EP Kind code of ref document: A1 |